抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Tislelizumab
All
TD-HS870066_1.jpg
TD-HS870066_2.jpg
TD-HS870066_3.jpg
- Catalog： TD-HS870066
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： BGB-A317,CAS:1858168-59-8
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Tislelizumab
| Catalog No. | TD-HS870066 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG4-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | Q15116 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | BGB-A317,CAS:1858168-59-8 |
| Background | Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Tislelizumab. |
|
|
Detects Human CD279/PDCD1/PD1 in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Tislelizumab. |